Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans.
It has been reported that lactoferrin (LF) participates in the host immune response against Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) invasion by enhancing NK cell activity and stimulating neutrophil aggregation and adhesion. We further investigated the role of LF in the entry of SARS...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3161750?pdf=render |
| _version_ | 1819171708146286592 |
|---|---|
| author | Jianshe Lang Ning Yang Jiejie Deng Kangtai Liu Peng Yang Guigen Zhang Chengyu Jiang |
| author_facet | Jianshe Lang Ning Yang Jiejie Deng Kangtai Liu Peng Yang Guigen Zhang Chengyu Jiang |
| author_sort | Jianshe Lang |
| collection | DOAJ |
| description | It has been reported that lactoferrin (LF) participates in the host immune response against Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) invasion by enhancing NK cell activity and stimulating neutrophil aggregation and adhesion. We further investigated the role of LF in the entry of SARS pseudovirus into HEK293E/ACE2-Myc cells. Our results reveal that LF inhibits SARS pseudovirus infection in a dose-dependent manner. Further analysis suggested that LF was able to block the binding of spike protein to host cells at 4°C, indicating that LF exerted its inhibitory function at the viral attachment stage. However, LF did not disrupt the interaction of spike protein with angiotensin-converting enzyme 2 (ACE2), the functional receptor of SARS-CoV. Previous studies have shown that LF colocalizes with the widely distributed cell-surface heparan sulfate proteoglycans (HSPGs). Our experiments have also confirmed this conclusion. Treatment of the cells with heparinase or exogenous heparin prevented binding of spike protein to host cells and inhibited SARS pseudovirus infection, demonstrating that HSPGs provide the binding sites for SARS-CoV invasion at the early attachment phase. Taken together, our results suggest that, in addition to ACE2, HSPGs are essential cell-surface molecules involved in SARS-CoV cell entry. LF may play a protective role in host defense against SARS-CoV infection through binding to HSPGs and blocking the preliminary interaction between SARS-CoV and host cells. Our findings may provide further understanding of SARS-CoV pathogenesis and aid in treatment of this deadly disease. |
| first_indexed | 2024-12-22T19:55:35Z |
| format | Article |
| id | doaj.art-bb204b66c65b46fd94ff709cf2751ffb |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T19:55:35Z |
| publishDate | 2011-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-bb204b66c65b46fd94ff709cf2751ffb2022-12-21T18:14:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0168e2371010.1371/journal.pone.0023710Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans.Jianshe LangNing YangJiejie DengKangtai LiuPeng YangGuigen ZhangChengyu JiangIt has been reported that lactoferrin (LF) participates in the host immune response against Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) invasion by enhancing NK cell activity and stimulating neutrophil aggregation and adhesion. We further investigated the role of LF in the entry of SARS pseudovirus into HEK293E/ACE2-Myc cells. Our results reveal that LF inhibits SARS pseudovirus infection in a dose-dependent manner. Further analysis suggested that LF was able to block the binding of spike protein to host cells at 4°C, indicating that LF exerted its inhibitory function at the viral attachment stage. However, LF did not disrupt the interaction of spike protein with angiotensin-converting enzyme 2 (ACE2), the functional receptor of SARS-CoV. Previous studies have shown that LF colocalizes with the widely distributed cell-surface heparan sulfate proteoglycans (HSPGs). Our experiments have also confirmed this conclusion. Treatment of the cells with heparinase or exogenous heparin prevented binding of spike protein to host cells and inhibited SARS pseudovirus infection, demonstrating that HSPGs provide the binding sites for SARS-CoV invasion at the early attachment phase. Taken together, our results suggest that, in addition to ACE2, HSPGs are essential cell-surface molecules involved in SARS-CoV cell entry. LF may play a protective role in host defense against SARS-CoV infection through binding to HSPGs and blocking the preliminary interaction between SARS-CoV and host cells. Our findings may provide further understanding of SARS-CoV pathogenesis and aid in treatment of this deadly disease.http://europepmc.org/articles/PMC3161750?pdf=render |
| spellingShingle | Jianshe Lang Ning Yang Jiejie Deng Kangtai Liu Peng Yang Guigen Zhang Chengyu Jiang Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS ONE |
| title | Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. |
| title_full | Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. |
| title_fullStr | Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. |
| title_full_unstemmed | Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. |
| title_short | Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. |
| title_sort | inhibition of sars pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans |
| url | http://europepmc.org/articles/PMC3161750?pdf=render |
| work_keys_str_mv | AT jianshelang inhibitionofsarspseudoviruscellentrybylactoferrinbindingtoheparansulfateproteoglycans AT ningyang inhibitionofsarspseudoviruscellentrybylactoferrinbindingtoheparansulfateproteoglycans AT jiejiedeng inhibitionofsarspseudoviruscellentrybylactoferrinbindingtoheparansulfateproteoglycans AT kangtailiu inhibitionofsarspseudoviruscellentrybylactoferrinbindingtoheparansulfateproteoglycans AT pengyang inhibitionofsarspseudoviruscellentrybylactoferrinbindingtoheparansulfateproteoglycans AT guigenzhang inhibitionofsarspseudoviruscellentrybylactoferrinbindingtoheparansulfateproteoglycans AT chengyujiang inhibitionofsarspseudoviruscellentrybylactoferrinbindingtoheparansulfateproteoglycans |